Home » Chugai Forced to Revise Overseas Strategy for Diabetes Drug
Chugai Forced to Revise Overseas Strategy for Diabetes Drug
Chugai Pharmaceutical said Swiss drugmaker F. Hoffmann-La Roche has returned the overseas development and sales rights to the Japanese firm’s diabetes treatment.
NIKKEI
NIKKEI
Upcoming Events
-
07May
-
14May
-
23May
-
30May
-
20Jun
-
21Oct